Cargando…

Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice

AIMS/HYPOTHESIS: Acetyl coenzyme A acetyltransferase (ACAT), also known as acetoacetyl-CoA thiolase, catalyses the formation of acetoacetyl-CoA from acetyl-CoA and forms part of the isoprenoid biosynthesis pathway. Thus, ACAT plays a central role in cholesterol metabolism in a variety of cells. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhimin, Huang, Zhengyun, Zhang, Chi, Liu, Xiangpeng, Zhang, Jie, Shu, Hui, Ma, Yue, Liu, Zhiwei, Feng, Yu, Chen, Xiyue, Kuang, Shihuan, Zhang, Yong, Jia, Zhihao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665029/
https://www.ncbi.nlm.nih.gov/pubmed/36378328
http://dx.doi.org/10.1007/s00125-022-05829-9
_version_ 1784831208229699584
author Ma, Zhimin
Huang, Zhengyun
Zhang, Chi
Liu, Xiangpeng
Zhang, Jie
Shu, Hui
Ma, Yue
Liu, Zhiwei
Feng, Yu
Chen, Xiyue
Kuang, Shihuan
Zhang, Yong
Jia, Zhihao
author_facet Ma, Zhimin
Huang, Zhengyun
Zhang, Chi
Liu, Xiangpeng
Zhang, Jie
Shu, Hui
Ma, Yue
Liu, Zhiwei
Feng, Yu
Chen, Xiyue
Kuang, Shihuan
Zhang, Yong
Jia, Zhihao
author_sort Ma, Zhimin
collection PubMed
description AIMS/HYPOTHESIS: Acetyl coenzyme A acetyltransferase (ACAT), also known as acetoacetyl-CoA thiolase, catalyses the formation of acetoacetyl-CoA from acetyl-CoA and forms part of the isoprenoid biosynthesis pathway. Thus, ACAT plays a central role in cholesterol metabolism in a variety of cells. Here, we aimed to assess the effect of hepatic Acat2 overexpression on cholesterol metabolism and systemic energy metabolism. METHODS: We generated liver-targeted adeno-associated virus 9 (AAV9) to achieve hepatic Acat2 overexpression in mice. Mice were injected with AAV9 through the tail vein and subjected to morphological, physiological (body composition, indirect calorimetry, treadmill, GTT, blood biochemistry, cardiac ultrasonography and ECG), histochemical, gene expression and metabolomic analysis under normal diet or feeding with high-fat diet to investigate the role of ACAT2 in the liver. RESULTS: Hepatic Acat2 overexpression reduced body weight and total fat mass, elevated the metabolic rate, improved glucose tolerance and lowered the serum cholesterol level of mice. In addition, the overexpression of Acat2 inhibited fatty acid, glucose and ketone metabolic pathways but promoted cholesterol metabolism and changed the bile acid pool and composition of the liver. Hepatic Acat2 overexpression also decreased the size of white adipocytes and promoted lipid metabolism in white adipose tissue. Furthermore, hepatic Acat2 overexpression protected mice from high-fat-diet-induced weight gain and metabolic defects CONCLUSIONS/INTERPRETATION: Our study identifies an essential role for ACAT2 in cholesterol metabolism and systemic energy expenditure and provides key insights into the metabolic benefits of hepatic Acat2 overexpression. Thus, adenoviral Acat2 overexpression in the liver may be a potential therapeutic tool in the treatment of obesity and hypercholesterolaemia. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed and unedited supplementary material available at 10.1007/s00125-022-05829-9.
format Online
Article
Text
id pubmed-9665029
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96650292022-11-16 Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice Ma, Zhimin Huang, Zhengyun Zhang, Chi Liu, Xiangpeng Zhang, Jie Shu, Hui Ma, Yue Liu, Zhiwei Feng, Yu Chen, Xiyue Kuang, Shihuan Zhang, Yong Jia, Zhihao Diabetologia Article AIMS/HYPOTHESIS: Acetyl coenzyme A acetyltransferase (ACAT), also known as acetoacetyl-CoA thiolase, catalyses the formation of acetoacetyl-CoA from acetyl-CoA and forms part of the isoprenoid biosynthesis pathway. Thus, ACAT plays a central role in cholesterol metabolism in a variety of cells. Here, we aimed to assess the effect of hepatic Acat2 overexpression on cholesterol metabolism and systemic energy metabolism. METHODS: We generated liver-targeted adeno-associated virus 9 (AAV9) to achieve hepatic Acat2 overexpression in mice. Mice were injected with AAV9 through the tail vein and subjected to morphological, physiological (body composition, indirect calorimetry, treadmill, GTT, blood biochemistry, cardiac ultrasonography and ECG), histochemical, gene expression and metabolomic analysis under normal diet or feeding with high-fat diet to investigate the role of ACAT2 in the liver. RESULTS: Hepatic Acat2 overexpression reduced body weight and total fat mass, elevated the metabolic rate, improved glucose tolerance and lowered the serum cholesterol level of mice. In addition, the overexpression of Acat2 inhibited fatty acid, glucose and ketone metabolic pathways but promoted cholesterol metabolism and changed the bile acid pool and composition of the liver. Hepatic Acat2 overexpression also decreased the size of white adipocytes and promoted lipid metabolism in white adipose tissue. Furthermore, hepatic Acat2 overexpression protected mice from high-fat-diet-induced weight gain and metabolic defects CONCLUSIONS/INTERPRETATION: Our study identifies an essential role for ACAT2 in cholesterol metabolism and systemic energy expenditure and provides key insights into the metabolic benefits of hepatic Acat2 overexpression. Thus, adenoviral Acat2 overexpression in the liver may be a potential therapeutic tool in the treatment of obesity and hypercholesterolaemia. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed and unedited supplementary material available at 10.1007/s00125-022-05829-9. Springer Berlin Heidelberg 2022-11-15 2023 /pmc/articles/PMC9665029/ /pubmed/36378328 http://dx.doi.org/10.1007/s00125-022-05829-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ma, Zhimin
Huang, Zhengyun
Zhang, Chi
Liu, Xiangpeng
Zhang, Jie
Shu, Hui
Ma, Yue
Liu, Zhiwei
Feng, Yu
Chen, Xiyue
Kuang, Shihuan
Zhang, Yong
Jia, Zhihao
Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice
title Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice
title_full Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice
title_fullStr Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice
title_full_unstemmed Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice
title_short Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice
title_sort hepatic acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665029/
https://www.ncbi.nlm.nih.gov/pubmed/36378328
http://dx.doi.org/10.1007/s00125-022-05829-9
work_keys_str_mv AT mazhimin hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT huangzhengyun hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT zhangchi hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT liuxiangpeng hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT zhangjie hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT shuhui hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT mayue hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT liuzhiwei hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT fengyu hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT chenxiyue hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT kuangshihuan hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT zhangyong hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice
AT jiazhihao hepaticacat2overexpressionpromotessystemiccholesterolmetabolismandadiposelipidmetabolisminmice